Literature DB >> 15275468

What is the function of MSP-I on the malaria merozoite?

A A Holder1, M J Blackman.   

Abstract

In the absence o f any clear enzymatic activity, attempts to define the role of merozoite surface protein-I have focused mainly on analysis of its structure, on its interaction with the immune system and on binding assays. But how does our knowledge of the structure o f this protein contribute to functional studies? Are there data to suggest a role in the evasion of effective host immune responses? Binding studies have used the intact protein or various fragments and peptides, but do such approaches provide a reliable indicator of function? In this article, Tony Holder and Mike Blackman review these areas.

Entities:  

Year:  1994        PMID: 15275468     DOI: 10.1016/0169-4758(94)90025-6

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  18 in total

1.  Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19).

Authors:  Zhi-Hong Zhang; Pei-Hong Jiang; Ning-Jun Li; Mi Shi; Weida Huang
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  An engineered Plasmodium falciparum C-terminal 19-kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon-gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria.

Authors:  C Bisseye; L M Yindom; J Simporé; W D Morgan; A A Holder; J Ismaili
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

3.  Genetic diversity in merozoite surface protein-1 and 2 among Plasmodium falciparum isolates from malarious districts of tribal dominant state of Jharkhand, India.

Authors:  M M Hussain; M Sohail; R Kumar; O H Branch; T Adak; M Raziuddin
Journal:  Ann Trop Med Parasitol       Date:  2011-12

4.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar.

Authors:  Jung-Mi Kang; Sung-Ung Moon; Jung-Yeon Kim; Shin-Hyeong Cho; Khin Lin; Woon-Mok Sohn; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

6.  Primary structure of the variable region of monoclonal antibody 2B10, capable of inducing anti-idiotypic antibodies that recognize the C-terminal region of MSA-1 of Plasmodium falciparum.

Authors:  S Su; S Yang; R Ding; E A Davidson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  The merozoite surface protein 1 complex is a platform for binding to human erythrocytes by Plasmodium falciparum.

Authors:  Clara S Lin; Alessandro D Uboldi; Danushka Marapana; Peter E Czabotar; Christian Epp; Hermann Bujard; Nicole L Taylor; Matthew A Perugini; Anthony N Hodder; Alan F Cowman
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

8.  Antimalarial activity of cupredoxins: the interaction of Plasmodium merozoite surface protein 119 (MSP119) and rusticyanin.

Authors:  Isabel Cruz-Gallardo; Irene Díaz-Moreno; Antonio Díaz-Quintana; Antonio Donaire; Adrián Velázquez-Campoy; Rachel D Curd; Kaveri Rangachari; Berry Birdsall; Andres Ramos; Anthony A Holder; Miguel A De la Rosa
Journal:  J Biol Chem       Date:  2013-06-07       Impact factor: 5.157

9.  Genetic analysis of the merozoite surface protein-1 block 2 allelic types in Plasmodium falciparum clinical isolates from Lao PDR.

Authors:  Naly Khaminsou; Onanong Kritpetcharat; Jureerut Daduang; Lertchai Charerntanyarak; Panutas Kritpetcharat
Journal:  Malar J       Date:  2011-12-17       Impact factor: 2.979

10.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.